CQ11. Does TSH Suppression Therapy Reduce the Size of Tumors Diagnosed as Benign?

  • Shinichi Suzuki
  • Nobuhiro Fukunari
  • Kaori Kameyama
  • Megumi Miyakawa
  • Katsuhiro Tanaka
  • Yatsuka Hibi


Nodular lesions of the thyroid are detected in 4–7% of the general population and the incidence is higher in iodine-deficient areas. In autopsy studies, more than 50% of thyroids regarded as normal had nodules. Furthermore, the incidence of thyroid incidentaloma, that is, nodules incidentally detected on imaging studies, was also high at 13–67% [1]. This is likely due to the development of various imaging studies such as high-resolution ultrasonography which are increasingly likely to be performed and propagation of medical screening and “ningen dock” check-up increases.


Thyroid Hormone Thyroid Nodule Nodular Lesion Benign Nodule Bone Metabolism Marker 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Ezzat S, Sarti DA, Cain DR et al (1994) Thyroid incidentalomas. Prevalence by palpation and ultrasonography. Arch Intern Med 154:1838–1840 (NR)PubMedCrossRefGoogle Scholar
  2. 2.
    Gharib H, Papini E, Paschke R (2008) Thyroid nodules: a review of current guidelines, practices and prospects. Eur J Endocrinol 159:493–505 (SR)PubMedCrossRefGoogle Scholar
  3. 3.
    Cooper DS, Doherty GM, Haugen BR et al (2006) Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16:109–142 (SR)PubMedCrossRefGoogle Scholar
  4. 4.
    Gharib H, Papini E, Valcavi R et al (2006) American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract 12:63–103 (SR)PubMedGoogle Scholar
  5. 5.
    Pacini F, Schlumberger M, Dralle H et al (2006) European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 154:787–803 (SR)PubMedCrossRefGoogle Scholar
  6. 6.
    Wémeau JL, Caron P, Schvartz C et al (2002) Effects of thyroid-stimulating hormone suppression with levothyroxine in reducing the volume of solitary thyroid nodules and improving extranodular nonpalpable changes: a randomized, double-blind, placebo-controlled trial by the French Thyroid Research Group. J Clin Endocrinol Metab 87:4928–4934 (RCT)PubMedCrossRefGoogle Scholar
  7. 7.
    Castro MR, Caraballo PJ, Morris JC (2002) Effectiveness of thyroid hormone suppressive therapy in benign solitary thyroid nodules: a meta-analysis. J Clin Endocrinol Metab 87:4154–4159 (SR  <  RCT>)PubMedCrossRefGoogle Scholar
  8. 8.
    Zelmanovitz F, Genro S, Gross JL (1998) Suppressive therapy with levothyroxine for solitary thyroid nodules: a double-blind controlled clinical study and cumulative meta-analyses. J Clin Endocrinol Metab 83:3881–3885 (RCT)PubMedCrossRefGoogle Scholar
  9. 9.
    Reverter JL, Lucas A, Salinas I et al (1992) Suppressive therapy with levothyroxine for solitary thyroid nodules. Clin Endocrinol (Oxf) 36:25–28 (RCT)CrossRefGoogle Scholar
  10. 10.
    Papini E, Bacci V, Panunzi C et al (1993) A prospective randomized trial of levothyroxine suppressive therapy for solitary thyroid nodules. Clin Endocrinol (Oxf) 38:507–513 (RCT)CrossRefGoogle Scholar
  11. 11.
    LaRosa GL, Lupo L, Giuffrida D et al (1995) Levothyroxine and potassium iodide are both effective in treating benign solitary solid cold nodules of the thyroid. Ann Intern Med 122:1–8 (RCT)Google Scholar
  12. 12.
    Richter B, Neises G, Clar C et al (2002) Pharmacotherapy for thyroid nodules. A systematic review and meta-analysis. Endocrinol Metab Clin North Am 31:699–722 (SR  <  RCT>)PubMedCrossRefGoogle Scholar
  13. 13.
    Gharib H, Mazzaferri EL (1998) Thyroxine suppressive therapy in patients with nodular thyroid disease. Ann Intern Med 128:386–394 (SR  <  RCT>)PubMedGoogle Scholar
  14. 14.
    Sdano MT, Falciglia M, Welge JA et al (2005) Efficacy of thyroid hormone suppression for benign thyroid nodules: meta-analysis of randomized trials. Otolaryngol Head Neck Surg 133:391–396 (SR  <  RCT>)PubMedCrossRefGoogle Scholar
  15. 15.
    Koc M, Ersoz HO, Akipinar I et al (2002) Effects of low- and high-dose levothyroxine on thyroid nodule volume: a crossover placebo-controlled trial. Clin Endocrinol (Oxf) 57:621–628 (RCT)CrossRefGoogle Scholar
  16. 16.
    Papini E, Petrucci L, Guglielmi R et al (1998) Long-term changes in nodular goiter: a 5-year prospective randomized trial of levothyroxine suppressive therapy for benign cold thyroid nodules. J Clin Endocrinol Metab 83:780–783 (RCT)PubMedCrossRefGoogle Scholar
  17. 17.
    Bennedbek FN, Hegedüs L (2000) Management of the solitary thyroid nodule: results of a North American survey. J Clin Endocrinol Metab 85:2493–2498 (NR)CrossRefGoogle Scholar
  18. 18.
    Biondi B, Palmieri EA, Klain M et al (2005) Subclinical hyperthyroidism: clinical features and treatment opinions. Eur J Endocrinol 152:1–9 (SR  <  PS, RCT>)PubMedCrossRefGoogle Scholar
  19. 19.
    Bauer DC, Ettinger B, Nevitt MC et al (2001) Risk for fracture in women with low serum levels of thyroid-stimulating hormone. Ann Intern Med 134:561–568 (RCT)PubMedGoogle Scholar
  20. 20.
    Vestergaard P, Mosekilde L (2003) Hypothyroidism, bone mineral, and fracture risk: a meta-analysis. Thyroid 13:585–593 (SR  <  PS>)PubMedCrossRefGoogle Scholar

Copyright information

© Springer Japan 2013

Authors and Affiliations

  • Shinichi Suzuki
    • 1
  • Nobuhiro Fukunari
    • 2
  • Kaori Kameyama
    • 3
  • Megumi Miyakawa
    • 4
  • Katsuhiro Tanaka
    • 5
  • Yatsuka Hibi
    • 6
  1. 1.Department of Organ Regulation SurgeryFukushima Medical University, School of MedicineFukushimaJapan
  2. 2.Department of SurgeryShowa University Northern Yokohama HospitalYokohamaJapan
  3. 3.Department of Diagnostic PathologyKeio University School of MedicineTokyoJapan
  4. 4.Endocrine CenterToranomon HospitalTokyoJapan
  5. 5.Department of Breast and Thyroid SurgeryKawasaki Medical SchoolKurashikiJapan
  6. 6.Department of Endocrine SurgeryFujita Health University School of MedicineToyoakeJapan

Personalised recommendations